Lilac Biosciences Appoints Adriana Coll De Peña as CEO
Providence, Rhode Island, USA, November 5, 2026 Lilac Biosciences Inc., a biotechnology company and Brown University spinout focused on...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine solid tumors targeted therapy
Providence, Rhode Island, USA, November 5, 2026 Lilac Biosciences Inc., a biotechnology company and Brown University spinout focused on...
Houston, Texas, USA, November 5, 2026 ImmunoGenesis, a clinical-stage biotechnology company focused on developing innovative cancer immunotherapies, has announced...
Boston, Massachusetts, USA, November 5, 2026 Skyhawk Therapeutics, Inc. has announced that the first patients in the United States...
Shanghai and Hong Kong, China, November 8, 2026 Antengene Corporation Limited has announced the presentation of promising preclinical research...
Missoula, Montana, USA, November 6, 2026 Inimmune Corporation, a clinical-stage biotechnology company developing innovative immunotherapies and immune-modulating technologies, has...
WALTHAM, Massachusetts, November 5, 2026 Thermo Fisher Scientific has introduced its new Thermo Scientific AmpSure Universal SYBR Green and...
Cambridge, Massachusetts, USA, November 3, 2026 Safi Biotherapeutics, a biotechnology company specializing in advanced blood cell manufacturing, has announced...
New York, USA, November 3, 2026 Graviton BioScience Corporation has announced that the U.S. Food and Drug Administration (FDA)...
CAMBRIDGE, Massachusetts, U.S., October 29, 2026 Flagship Pioneering has announced the formation of Etcelera, a biotechnology company designed to...
Austin, Texas, United States, October 28, 2026 Genprex, Inc. has announced that research from its sponsored collaboration with Meharry...
